Altai Protocol Library New Protocol: Cytarabine – MitoXANtrone – Venetoclax for Rel/Ref AML U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Indication: Adjuvant Trastuzumab Deruxtecan for Residual Her2-Positive Breast Cancer U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Reference: Tislelizumab with Chemotherapy for Nasopharyngeal Carcinoma U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Protocol: Teclistamab with Daratumumab for Rel/Ref Multiple Myeloma U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Drug: Pivekimab Sunirine for Blastic Plasmacytoid Dendritic Cell Neoplasm U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Reference: Long Term Survival with Nivolumab-Ipilimumab in Advanced RCC U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Protocol: Neoadjuvant GOLP for Cholangiocarcinoma U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Reference: Periop Enfortumab Vedotin and Pembrolizumab for Bladder Cancer U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Protocol: Eflornithine with Lomustine for Recurrent Astrocytoma U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Protocol: Datopotamab Deruxtecan with Osimertinib for EGFR-Mutated NSCLC U. Darda Bayraktar, MD 2026-03-12
